Glenmark Recalls ADHD Medication in US: USFDA
March 2, 2025 11:44
Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine impurity above the FDA limit. The recall is classified as Class II, meaning...